Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 3, 2012, Pages 385-395

  Thompson, Scott M ^a   Callstrom, Matthew R ^b   Knudsen, Bruce ^b   Anderson, Jill L ^b   Carter, Rickey E ^a   Grande, Joseph P ^b   Roberts, Lewis R ^b   Woodrum, David A ^b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL LABORATORY RESULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; HISTOPATHOLOGY; IMAGE GUIDED RADIOTHERAPY; INTERVENTIONAL RADIOLOGY; LASER SURGERY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SUPERIOR MESENTERIC ANGIOGRAPHY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME;

ANIMALS; AORTOGRAPHY; BILE DUCTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; LASER THERAPY; LIGATION; LIVER CIRRHOSIS; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; NEOPLASM INVASIVENESS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSLATIONAL MEDICAL RESEARCH; TUMOR BURDEN;

EID: 84862777362     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.11.018     Document Type: Article

References (32)

1. R.N. Aravalli, J. Golzarian, E.N. Cressman Animal models of cancer in interventional radiology Eur Radiol 19 2009 1049 1053
2. R.N. Aravalli, C.J. Steer, M.B. Sahin, E.N. Cressman Stem cell origins and animal models of hepatocellular carcinoma Dig Dis Sci 55 2010 1241 1250
3. X. Li, X. Zhou, Y. Guan, Y.X. Wang, D. Scutt, Q.Y. Gong N-nitrosodiethylamine-induced pig liver hepatocellular carcinoma model: radiological and histopathological studies Cardiovasc Intervent Radiol 29 2006 420 428
4. W. Yang, M. Ahmed, M. Elian Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology 257 2010 685 696
5. Y. Guo, R. Klein, R.A. Omary, G.Y. Yang, A.C. Larson Highly malignant intra-hepatic metastatic hepatocellular carcinoma in rats Am J Transl Res 3 2010 114 120
6. S. Ju, G. McLennan, S.L. Bennett Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers J Vasc Interv Radiol 20 2009 410 414
7. W.Y. Lin, S.C. Tsai, J.F. Hsieh, S.J. Wang Effects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method J Nucl Med 41 2000 1892 1897
8. Y. Guo, Y. Zhang, R. Klein Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma Cancer Res 70 2010 1555 1563
9. H.H. Chan, T.H. Chu, H.F. Chien Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation BMC Gastroenterol 10 2010 83
10. J.D. Yang, W.R. Kim, R. Coelho Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma Clin Gastroenterol Hepatol 9 2011 64 70
11. J.D. Yang, I. Nakamura, L.R. Roberts The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets Semin Cancer Biol 21 2011 35 43
12. W.Y. Chen, C.J. Chen, J.W. Liao, F.C. Mao Chromium attenuates hepatic damage in a rat model of chronic cholestasis Life Sci 84 2009 606 614
13. T. Tsujimoto, S. Kuriyama, M. Yamazaki Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers Int J Oncol 18 2001 41 47
14. U. Mayrhauser, P. Stiegler, V. Stadlbauer Effect of hyperthermia on liver cell lines: important findings for thermal therapy in hepatocellular carcinoma Anticancer Res 31 2011 1583 1588
15. M.A. Aller, J.L. Arias, I. Prieto, J. Arias A suitable microsurgical method for obstructive cholestasis in the rat Protocol Exchange 2010 10.1038/nprot.2010.56 http://www.nature.com/protocolexchange/protocols/647/ uploads/1411 Accessed October 1, 2010
16. S.N. Goldberg, C.J. Grassi, J.F. Cardella Image-guided tumor ablation: standardization of terminology and reporting criteria J Vasc Interv Radiol 20 2009 S377 S390
17. Y.K. Cho, Y. Kim, H. Rhim Pitfalls in the radiological and pathological correlation of tumour response rates of hepatocellular carcinoma following radiofrequency ablation J Clin Pathol 62 2009 1071 1073
18. X. Li, C.S. Zheng, G.S. Feng, C.K. Zhuo, J.G. Zhao, X. Liu An implantable rat liver tumor model for experimental transarterial chemoembolization therapy and its imaging features World J Gastroenterol 8 2002 1035 1039 (Pubitemid 35446416)
19. F. Chen, X. Sun, F. De Keyzer Liver tumor model with implanted rhabdomyosarcoma in rats: MR imaging, microangiography, and histopathologic analysis Radiology 239 2006 554 562
20. R.J. Stafford, D. Fuentes, A.A. Elliott, J.S. Weinberg, K. Ahrar Laser-induced thermal therapy for tumor ablation Crit Rev Biomed Eng 38 2010 79 100
21. A.L. Gough-Palmer, W.M. Gedroyc Laser ablation of hepatocellular carcinomaa review World J Gastroenterol 14 2008 7170 7174
22. C.T. Sofocleous, R.G. Nascimento, L.M. Petrovic Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results Radiology 249 2008 364 374
23. J.D. Yang, L.R. Roberts Epidemiology and management of hepatocellular carcinoma Infect Dis Clin North Am 24 2010 899 919
24. J. Wang, S. Zhang, Z. Li (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis Tumour Biol 32 2011 223 231
25. J.C. Mertens, I.V. Martin, J. Schmitt Multikinase inhibitor sorafenib transiently promotes necrosis after radiofrequency ablation in rat liver but activates growth signals Eur J Radiol 2011 May 16 10.1016/j.ejrad.2011.04.042 [Epub ahead of print]
26. K. Hoffmann, H. Glimm, B. Radeleff Prospective, randomized, double-blind, multi-center, phase III clinical study on transarterial chemoembolization (TACE) combined with sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794] BMC Cancer 8 2008 349
27. J.S. Lee, I.S. Chu, A. Mikaelyan Application of comparative functional genomics to identify best-fit mouse models to study human cancer Nat Genet 36 2004 1306 1311 (Pubitemid 39577940)
28. J.S. Lee, S.S. Thorgeirsson Comparative and integrative functional genomics of HCC Oncogene 25 2006 3801 3809 (Pubitemid 43980475)
29. J.B. Andersen, V.M. Factor, J.U. Marquardt An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer Sci Transl Med 2 2010 54ra77
30. J.T. Chi, D.E. Thrall, C. Jiang Comparison of genomics and functional imaging from canine sarcomas treated with thermoradiotherapy predicts therapeutic response and identifies combination therapeutics Clin Cancer Res 17 2011 2549 2560
31. G.J. Becker Interventional oncology: perspectives on current scholarly productivity and potential for future growth Radiology 257 2010 309 312
32. R.J. Lewandowski, J.F. Geschwind, E. Liapi, R. Salem Transcatheter intraarterial therapies: rationale and overview Radiology 259 2011 641 657